Equities analysts forecast that Cardinal Health Inc (NYSE:CAH) will report earnings of $1.45 per share for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Cardinal Health’s earnings, with the lowest EPS estimate coming in at $1.41 and the highest estimate coming in at $1.50. Cardinal Health posted earnings per share of $1.59 during the same quarter last year, which would suggest a negative year-over-year growth rate of 8.8%. The company is expected to issue its next earnings results on Thursday, May 14th.

On average, analysts expect that Cardinal Health will report full year earnings of $5.33 per share for the current fiscal year, with EPS estimates ranging from $5.05 to $5.50. For the next year, analysts anticipate that the business will report earnings of $5.54 per share, with EPS estimates ranging from $5.30 to $5.77. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Cardinal Health.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.30. Cardinal Health had a negative net margin of 2.81% and a positive return on equity of 45.21%. The firm had revenue of $39.77 billion for the quarter, compared to analysts’ expectations of $39.33 billion. During the same period last year, the firm earned $1.29 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis.

A number of equities analysts have issued reports on the stock. TheStreet cut shares of Cardinal Health from a “c+” rating to a “d” rating in a research note on Thursday, November 7th. Robert W. Baird raised shares of Cardinal Health from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $54.00 to $68.00 in a research note on Friday, February 7th. ValuEngine cut shares of Cardinal Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 6th. Morgan Stanley raised shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $48.00 to $64.00 in a research report on Wednesday. Finally, Zacks Investment Research raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $61.00 price target on the stock in a research report on Friday, February 7th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. Cardinal Health currently has an average rating of “Hold” and a consensus price target of $58.88.

CAH stock traded up $0.22 during midday trading on Friday, reaching $59.62. The company’s stock had a trading volume of 3,247,643 shares, compared to its average volume of 2,962,512. Cardinal Health has a 52 week low of $41.03 and a 52 week high of $60.69. The stock has a market cap of $17.27 billion, a PE ratio of -4.18, a price-to-earnings-growth ratio of 1.79 and a beta of 1.36. The company has a quick ratio of 0.48, a current ratio of 1.03 and a debt-to-equity ratio of 6.73. The business’s 50-day simple moving average is $53.26 and its 200-day simple moving average is $50.10.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a dividend of $0.4811 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 3.23%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.48. The ex-dividend date is Tuesday, March 31st. Cardinal Health’s dividend payout ratio (DPR) is currently 36.36%.

Several hedge funds and other institutional investors have recently made changes to their positions in CAH. Point72 Asset Management L.P. boosted its position in shares of Cardinal Health by 12,324.4% during the third quarter. Point72 Asset Management L.P. now owns 683,344 shares of the company’s stock worth $32,247,000 after purchasing an additional 677,844 shares in the last quarter. State Street Corp boosted its position in shares of Cardinal Health by 3.1% during the third quarter. State Street Corp now owns 21,778,838 shares of the company’s stock worth $1,038,087,000 after purchasing an additional 650,769 shares in the last quarter. Exchange Traded Concepts LLC bought a new position in shares of Cardinal Health during the fourth quarter worth $25,135,000. Bank of Montreal Can boosted its position in shares of Cardinal Health by 165.5% during the fourth quarter. Bank of Montreal Can now owns 754,062 shares of the company’s stock worth $38,140,000 after purchasing an additional 470,021 shares in the last quarter. Finally, Pzena Investment Management LLC lifted its position in Cardinal Health by 9.1% in the 4th quarter. Pzena Investment Management LLC now owns 4,000,397 shares of the company’s stock valued at $202,340,000 after acquiring an additional 332,713 shares in the last quarter. 89.07% of the stock is currently owned by institutional investors.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

See Also: Closed-End Mutual Funds

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.